SEARCH

SEARCH BY CITATION

References

  • 1
    Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010; 36: S8S14.
  • 2
    Patel G, Bonomo RA. Status report on carbapenemases: challenges and prospects. Expert Rev Anti Infect Ther 2011; 9: 555570.
  • 3
    Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440458.
  • 4
    Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 17911798.
  • 5
    Walsh TR, Toleman MA, Poirel L et al. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18: 306325.
  • 6
    Yigit H, Queenan AM, Anderson GJ et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 11511161.
  • 7
    Poirel L, Héritier C, Tolün V et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48: 1522.
  • 8
    Yong D, Toleman MA, Giske CG et al. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53: 50465054.
  • 9
    Cantón R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006; 9: 466475.
  • 10
    Rodríguez-Baño J, Pascual A. Clinical significance of extended-spectrum β-lactamases. Expert Rev Anti Infect Ther 2008; 6: 671683.
  • 11
    Valverde A, Coque TM, García-San Miguel L et al. Complex molecular epidemiology of extended-spectrum β-lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid. J Antimicrob Chemother 2008; 61: 6472.
  • 12
    Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35: 316321.
  • 13
    Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2007; 2: 501512.
  • 14
    Cantón R, Novais A, Valverde A et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008; 14: 144153.
  • 15
    Nordmann P, Poirel L, Toleman MA et al. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother 2011; 66: 689692.
  • 16
    Grundmann H, Livermore DM, Giske CG et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 2010; 15: pii: 19711.
  • 17
    Cantón R, Ruiz-Garbajosa P. Co-resistance: an opportunity for the bacteria and resistance genes. Curr Opin Pharmacol 2011; 11: 477485.
  • 18
    Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35: 736755.
  • 19
    Pitout JD. The latest threat in the war on antimicrobial resistance. Lancet Infect Dis 2010; 10: 578579.
  • 20
    European Centre for Disease Prevention and Control. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities. Stockholm: ECDC; 2011.
  • 21
    Naas T, Nordmann P, Vedel G et al. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 2005; 49: 44234424.
  • 22
    Potron A, Poirel L, Verdavaine D et al. Importation of KPC-2-producing Escherichia coli from India. J Antimicrob Chemother 2012; 67: 242243.
  • 23
    Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597602.
  • 24
    Levast M, Poirel L, Carrër A et al. Transfer of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae from Turkey to France. J Antimicrob Chemother 2011; 66: 944945.
  • 25
    Poirel L, Bernabeu S, Fortineau N et al. Emergence of OXA-48-producing Escherichia coli clone ST38 in France. Antimicrob Agents Chemother 2011; 55: 49374938.
  • 26
    Pitart C, Solé M, Roca I et al. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 β-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 2011; 55: 43984401.
  • 27
    Miriagou V, Cornaglia G, Edelstein M et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010; 16: 112122.
  • 28
    Thomson KS. Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues. J Clin Microbiol 2010; 48: 10191025.
  • 29
    Kassis-Chikhani N, Decré D, Gautier V et al. First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital. J Antimicrob Chemother 2006; 57: 142145.
  • 30
    Cuzon G, Naas T, Demachy MC et al. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 2008; 52: 796797.
  • 31
    Vatopoulos A. High rates of metallo-β-lactamase-producing Klebsiella pneumoniae in Greece—a review of the current evidence. Euro Surveill 2008; 13: pii: 8023.
  • 32
    Miriagou V, Tzelepi E, Gianneli D et al. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1. Antimicrob Agents Chemother 2003; 47: 395397.
  • 33
    Scoulica EV, Neonakis IK, Gikas AI, Tselentis YJ. Spread of bla(VIM-1)-producing E. coli in a university hospital in Greece. Genetic analysis of the integron carrying the bla(VIM-1) metallo-beta-lactamase gene. Diagn Microbiol Infect Dis. 2004; 48: 167172.
  • 34
    Giakkoupi P, Xanthaki A, Kanelopoulou M et al. VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 2003; 41: 38933896.
  • 35
    Ikonomidis A, Tokatlidou D, Kristo I et al. Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a bla VIM-1 metallo-β-lactamase gene. J Clin Microbiol 2005; 43: 53445347.
  • 36
    Miriagou V, Papagiannitsis CC, Kotsakis SD et al. Sequence of pNL194, a 79.3-kilobase IncN plasmid carrying the blaVIM-1 metallo-β-lactamase gene in Klebsiella pneumoniae. Antimicrob Agents Chemother 2010; 54: 44974502.
  • 37
    Tokatlidou D, Tsivitanidou M, Pournaras S et al. Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital. J Clin Microbiol 2008; 46: 10051008.
  • 38
    Ikonomidis A, Spanakis N, Poulou A et al. Emergence of carbapenem-resistant Enterobacter cloacae carrying VIM-4 metallo-β-lactamase and SHV-2a extended-spectrum β-lactamase in a conjugative plasmid. Microb Drug Resist 2007; 13: 221226.
  • 39
    Galani I, Souli M, Koratzanis E et al. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in Greece. J Antimicrob Chemother 2007; 59: 578579.
  • 40
    Tsakris A, Kristo I, Poulou A et al. First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J Antimicrob Chemother 2008; 62: 12571260.
  • 41
    Maltezou HC, Giakkoupi P, Maragos A et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 2009; 58: 213219.
  • 42
    Samuelsen Ø, Naseer U, Tofteland S et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother 2009; 63: 654658.
  • 43
    Giakkoupi P, Papagiannitsis CC, Miriagou V et al. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009–10). J Antimicrob Chemother 2011; 66: 15101513.
  • 44
    Pournaras S, Protonotariou E, Voulgari E et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009; 64: 348352.
  • 45
    Kontopoulou K, Protonotariou E, Vasilakos K et al. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistin. J Hosp Infect 2010; 76: 7073.
  • 46
    Mavroidi A, Miriagou V, Malli E et al. Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase. Int J Antimicrob Agents 2012; 39: 247250.
  • 47
    Oteo J, Hernández-Almaraz JL, Gil-Antón J et al. Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. Pediatr Infect Dis J 2010; 29: 11441146.
  • 48
    Nazic H, Poirel L, Nordmann P. Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey. Antimicrob Agents Chemother 2005; 49: 21462147.
  • 49
    Carrër A, Poirel L, Eraksoy H et al. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother 2008; 52: 29502954.
  • 50
    Gülmez D, Woodford N, Palepou MF et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008; 31: 523526.
  • 51
    Kilic A, Aktas Z, Bedir O et al. Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteriaceae isolates in Turkey. Ann Clin Lab Sci 2011; 41: 161166.
  • 52
    Carrër A, Poirel L, Yilmaz M et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 2010; 54: 13691373.
  • 53
    Potron A, Kalpoe J, Poirel L et al. European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect 2011; 17: E24E26.
  • 54
    Gacar GG, Midilli K, Kolayli F et al. Genetic and enzymatic properties of metallo-β-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae. Antimicrob Agents Chemother 2005; 49: 44004403.
  • 55
    Bahar G, Mazzariol A, Koncan R et al. Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. J Antimicrob Chemother 2004; 54: 282283.
  • 56
    Ozgumus OB, Caylan R, Tosun I, Sandalli C, Aydin K, Koksal I. Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-β-lactamase gene in a university hospital in Turkey. Microb Drug Resist 2007; 13: 191198.
  • 57
    Yildirim I, Ceyhan M, Gur D et al. First detection of VIM-1 type metallo-β-lactamase in a multidrug-resistant Klebsiella pneumoniae clinical isolate from Turkey also producing the CTX-M-15 extended-spectrum β-lactamase. J Chemother 2007; 19: 467468.
  • 58
    Samuelsen Ø, Toleman MA, Hasseltvedt V et al. Molecular characterisation of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin Microbiol Infect 2011; 17: 18111816.
  • 59
    Aktas Z, Bal C, Midilli K et al. First IMP-1-producing Klebsiella pneumoniae isolate in Turkey. Clin Microbiol Infect 2006; 12: 695696.
  • 60
    Deshpande LM, Jones RN, Fritsche TR, Sader HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000–2004). Microb Drug Resist 2006; 12: 223230.
  • 61
    Navon-Venezia S, Chmelnitsky I, Leavitt A et al. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006; 50: 30983101.
  • 62
    Marchaim D, Navon-Venezia S, Schwaber MJ et al. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008; 52: 14131418.
  • 63
    Colodner R, Samra Z, Keller N et al. First national surveillance of susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel. Diagn Microbiol Infect Dis 2007; 57: 201205.
  • 64
    Leavitt A, Chmelnitsky I, Colodner R et al. Ertapenem resistance among extended-spectrum-β-lactamase-producing Klebsiella pneumoniae isolates. J Clin Microbiol 2009; 47: 969974.
  • 65
    Leavitt A, Navon-Venezia S, Chmelnitsky I et al. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007; 51: 30263029.
  • 66
    Samra Z, Ofir O, Lishtzinsky Y et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007; 30: 525529.
  • 67
    Navon-Venezia S, Leavitt A, Schwaber MJ et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009; 53: 818820.
  • 68
    Kitchel B, Raseheed JK, Pate JB et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009; 53: 33653370.
  • 69
    Schwaber MJ, Lev B, Israeli A et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011; 52: 848855.
  • 70
    Ben-David D, Masarwa S, Navon-Venezia S et al. Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect Control Hosp Epidemiol 2011; 32: 845853.
  • 71
    Adler A, Shklyar M, Schwaber MJ et al. Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism. J Antimicrob Chemother 2011; 66: 27632766.
  • 72
    Cornaglia G, Riccio ML, Mazzariol A et al. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 1999; 353: 899900.
  • 73
    Riccio ML, Franceschini N, Boschi L et al. Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother 2000; 44: 12291235.
  • 74
    Lauretti L, Riccio ML, Mazzariol A et al. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999; 43: 15841590.
  • 75
    Riccio ML, Pallecchi L, Fontana R et al. In70 of plasmid pAX22, a blaVIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob Agents Chemother 2001; 45: 12491253.
  • 76
    Giani T, Marchese A, Coppo E et al. VIM-1-producing Pseudomonas mosselii isolated in Italy, pre-dating known VIM-producing index strains. Antimicrob Agents Chemother 2012. Jan 30 [Epub ahead of print].
  • 77
    Luzzaro F, Docquier JD, Colinon C et al. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid. Antimicrob Agents Chemother 2004; 48: 648650.
  • 78
    Aschbacher R, Doumith M, Livermore DM et al. Linkage of acquired quinolone resistance (qnrS1) and metallo-β-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy. J Antimicrob Chemother 2008; 61: 515523.
  • 79
    Perilli M, Mezzatesta ML, Falcone M et al. Class I integron-borne blaVIM-1 carbapenemase in a strain of Enterobacter cloacae responsible for a case of fatal pneumonia. Microb Drug Resist 2008; 14: 4547.
  • 80
    Rossolini GM, Luzzaro F, Migliavacca R et al. First countrywide survey of acquired metallo-β-lactamases in gram-negative pathogens in Italy. Antimicrob Agents Chemother 2008; 52: 40234029.
  • 81
    Cagnacci S, Gualco L, Roveta S et al. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-β-lactamase: first Italian outbreak. J Antimicrob Chemother 2008; 61: 296300.
  • 82
    Castanheira M, Debbia E, Marchese A et al. Emergence of a plasmid-mediated blaVIM-1 in Citrobacter koseri: report from the SENTRY Antimicrobial Surveillance Program (Italy). J Chemother 2009; 21: 98100.
  • 83
    Falcone M, Mezzatesta ML, Perilli M et al. Infections with VIM-1 metallo-β-lactamase-producing Enterobacter cloacae and their correlation with clinical outcome. J Clin Microbiol 2009; 47: 35143549.
  • 84
    Falcone M, Perilli M, Mezzatesta ML et al. Prolonged bacteraemia caused by VIM-1 metallo-β-lactamase-producing Proteus mirabilis: first report from Italy. Clin Microbiol Infect 2010; 16: 179181.
  • 85
    Aschbacher R, Pagani L, Doumith M et al. Metallo-β-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008. Clin Microbiol Infect 2011; 17: 181189.
  • 86
    Mantengoli E, Luzzaro F, Pecile P et al. Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options. Clin Infect Dis 2011; 52: 690691.
  • 87
    Giani T, D’Andrea MM, Pecile P et al. Emergence of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase, Italy. J Clin Microbiol 2009; 47: 37933794.
  • 88
    Fontana C, Favaro M, Sarmati L et al. Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res Notes 2010; 3: 40.
  • 89
    Ambretti S, Gaibani P, Caroli F et al. A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy. New Microbiol 2010; 33: 281282.
  • 90
    Marchese A, Coppo E, Barbieri R et al. Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. J Chemother 2010; 22: 212214.
  • 91
    Gaibani P, Ambretti S, Berlingeri A et al. Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March–30 September 2010. Euro Surveill 2011; 16: 19800.
  • 92
    Mezzatesta ML, Gona F, Caio C et al. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. Clin Microbiol Infect 2011; 17: 14441447.
  • 93
    Agodi A, Voulgari E, Barchitta M et al. Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J Clin Microbiol 2011; 49: 39863989.
  • 94
    Richter SN, Frasson I, Bergo C et al. Transfer of KPC-2 carbapenemase from Klebsiella pneumoniae to Escherichia coli in a patient: first case in Europe. J Clin Microbiol 2011; 49: 20402042.
  • 95
    Di Carlo P, Pantuso G, Cusimano A et al. Two cases of monomicrobial intraabdominal abscesses due to KPC-3 Klebsiella pneumoniae ST258 clone. BMC Gastroenterol 2011; 11: 103.
  • 96
    Mammina C, Palma DM, Bonura C et al. Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae carbapenemase 3 in an intensive care unit in Italy. J Clin Microbiol 2010; 48: 15061507.
  • 97
    Gaibani P, Ambretti S, Berlingeri A et al. Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011. Euro Surveill 2011; 16: 20027.
  • 98
    Giani T, Conte V, Di Pilato V et al. OXA-48 carbapenemase-producing Escherichia coli from Italy, encoded by a novel Tn1999 transposon derivative. Antimicrob Agents Chemother 2012. Jan 30 [Epub ahead of print].
  • 99
    Sardelic S, Pallecchi L, Punda-Polic V et al. Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-β-lactamase determinants, Croatia. Emerg Infect Dis 2003; 9: 10221023.
  • 100
    Bosnjak Z, Bedenić B, Mazzariol A et al. VIM-2 β-lactamase in Pseudomonas aeruginosa isolates from Zagreb, Croatia. Scand J Infect Dis 2010; 42: 193197.
  • 101
    Franolić-Kukina I, Bedenić B, Budimir A et al. Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian university hospital. Int J Infect Dis 2011; 15: e706e709.
  • 102
    Goic-Barisic I, Towner KJ, Kovacic A et al. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. J Hosp Infect 2011; 77: 368369.
  • 103
    Pirs M, Andlovic A, Cerar T et al. A case of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a patient transferred to Slovenia from Libya, November 2011. Euro Surveill 2011; 16: pii: 20042.
  • 104
    Bogaerts P, Bouchahrouf W, de Castro RR et al. Emergence of NDM-1-producing Enterobacteriaceae 1 in Belgium. Antimicrob Agents Chemother 2011; 55: 30363038.
  • 105
    Tórtola MT, Lavilla S, Miró E et al. First detection of a carbapenem-hydrolyzing metalloenzyme in two Enterobacteriaceae isolates in Spain. Antimicrob Agents Chemother 2005; 49: 34923494.
  • 106
    Tato M, Coque TM, Ruíz-Garbajosa P et al. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-β-lactamase in Spain: toward endemicity? Clin Infect Dis 2007; 45: 11711178.
  • 107
    Curiao T, Morosini MI, Ruiz-Garbajosa P et al. Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother 2010; 65: 16081614.
  • 108
    Gómez-Gil MR, Paño-Pardo JR, Romero-Gómez MP et al. Detection of KPC-2-producing Citrobacter freundii isolates in Spain. J Antimicrob Chemother 2010; 65: 26952697.
  • 109
    Solé M, Pitart C, Roca I et al. First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother 2011; 55: 44024404.
  • 110
    Sánchez-Romero I, Asensio A, Oteo J et al. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 2012; 56: 420427.
  • 111
    Tato M, Coque TM, Baquero F et al. Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2010; 54: 320327.
  • 112
    Miró E, Segura C, Navarro F et al. Spread of plasmids containing the bla(VIM-1) and bla(CTX-M) genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates. J Antimicrob Chemother 2010; 65: 661665.
  • 113
    Cendejas E, Gómez-Gil R, Gómez-Sánchez P et al. Detection and characterization of Enterobacteriaceae producing metallo-β-lactamases in a tertiary-care hospital in Spain. Clin Microbiol Infect 2010; 16: 181183.
  • 114
    Treviño M, Navarro D, Barbeito G et al. Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight. Microb Drug Resist 2011; 17: 433442.
  • 115
    Sorlí L, Miró E, Segura C et al. Intra- and inter-species spread of carbapenemase genes in a non-hospitalized patient. Eur J Clin Microbiol Infect Dis 2011; 30: 15511555.
  • 116
    Struelens MJ, Monnet DL, Magiorakos AP et al. New Delhi metallo-β-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010; 15: pii: 19716.
  • 117
    Cuzon G, Ouanich J, Gondret R et al. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 2011; 55: 24202423.
  • 118
    Scotta C, Juan C, Cabot G et al. Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-β-lactamases. Antimicrob Agents Chemother 2011; 55: 53765379.
  • 119
    Conceição T, Brízio A, Duarte A et al. First isolation of bla(VIM-2) in Klebsiella oxytoca clinical isolates from Portugal. Antimicrob Agents Chemother 2005; 49: 476.
  • 120
    Poirel L, Barbosa-Vasconcelos A, Simões RR et al. Environmental KPC-producing Escherichia coli, Portugal. Antimicrob Agents Chemother 2012; 56: 16621663.
  • 121
    Naas T, Nordmann P. Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc Natl Acad Sci USA 1994; 91: 76937697.
  • 122
    Lartigue MF, Poirel L, Nordmann P. First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France. Antimicrob Agents Chemother 2004; 48: 49294930.
  • 123
    Rodriguez-Martinez JM, Nordmann P, Fortineau N, Poirel L. VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob Agents Chemother 2010; 54: 471476.
  • 124
    Vidal-Navarro L, Pfeiffer C, Bouziges N et al. Faecal carriage of multidrug-resistant Gram-negative bacilli during a non-outbreak situation in a French university hospital. J Antimicrob Chemother 2010; 65: 24552458.
  • 125
    Poirel L, Hombrouck-Alet C, Freneaux C et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010; 10: 597602.
  • 126
    Poirel L, Ros A, Carricajo A et al. Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother 2011; 55: 447448.
  • 127
    Poirel L, Fortineau N, Nordmann P. International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob Agents Chemother 2011; 55: 18211822.
  • 128
    Nordmann P, Couard JP, Sansot D, Poirel L. Emergence of an autochthonous and community-acquired NDM-1-producing Klebsiella pneumoniae in Europe. Clin Infect Dis 2012; 54: 150151.
  • 129
    Denis C, Poirel L, Carricajo A et al. Nosocomial transmission of NDM-1-producing Escherichia coli within a non-endemic area in France. Clin Microbiol Infect 2012. Jan 2 [Epub ahead of print].
  • 130
    Diene M, Bruder N, Raoult D, Rolain JM. Real-time PCR assay allows detection of the New Delhi metallo-β-lactamase (NDM-1)-encoding gene in France. Int J Antimicrob Agents 2011; 37: 544546.
  • 131
    Naas T, Ergani A, Carrër A, Nordmann P. Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrob Agents Chemother 2011; 55: 40384043.
  • 132
    Birgy A, Doit C, Mariani-Kurkdjian P et al. Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. J Clin Microbiol 2011; 49: 30853087.
  • 133
    Petrella S, Ziental-Gelus N, Mayer C et al. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A β-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob Agents Chemother 2008; 52: 37253736.
  • 134
    Dortet L, Radu I, Gautier V et al. Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1. J Antimicrob Chemother 2008; 61: 455457.
  • 135
    Cuzon G, Naas T, Demachy MC, Nordmann P. Nosocomial outbreak of Klebsiella pneumoniae harboring blaKPC-3 in France subsequent to a patient transfer from Italy. Int J Antimicrob Agents, 2012. Mar 13 [Epub ahead of print].
  • 136
    Naas T, Cuzon G, Babics A et al. Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase. J Antimicrob Chemother 2010; 65: 13051306.
  • 137
    Carbonne A, Thiolet JM, Fournier S et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 2010; 15: pii: 19734.
  • 138
    Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228236.
  • 139
    Naas T, Cuzon G, Gaillot O et al. When carbapenem-hydrolyzing β-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob Agents Chemother 2011; 55: 49334934.
  • 140
    Naas T, Cattoen C, Bernusset S et al. First identification of blaIMI-1 in an Enterobacter cloacae clinical isolate from France. Antimicrob Agents Chemother. 2012; 56: 16641665.
  • 141
    Cuzon G, Naas T, Lesenne A, Benhamou M, Nordmann P. Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia. Int J Antimicrob Agents 2010; 36: 9193.
  • 142
    Decre D, Birgand G, Geneste D et al. Possible importation and subsequent cross-transmission of OXA-48-producing Klebsiella pneumoniae, France, 2010. Euro Surveill 2010; 15: pii: 197.
  • 143
    Poirel L, Ros A, Carrër A et al. Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. J Antimicrob Chemother 2011; 66: 11811182.
  • 144
    Ruppé E, Armand-Lefèvre L, Lolom I et al. Development of a phenotypic method for detection of fecal carriage of OXA-48-producing enterobacteriaceae after incidental detection from clinical specimen. J Clin Microbiol 2011; 49: 27612762.
  • 145
    Kristóf K, Tóth A, Damjanova I et al. Identification of a blaVIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary. J Antimicrob Chemother 2010; 65: 13031305.
  • 146
    Potron A, Nordmann P, Lafeuille E et al. Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 2011; 55: 48964899.
  • 147
    Poirel L, Wenger A, Bille J et al. SME-2-producing Serratia marcescens isolate from Switzerland. Antimicrob Agents Chemother 2007; 51: 22822283.
  • 148
    Poirel L, Lienhard R, Potron A et al. Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland. J Antimicrob Chemother 2011; 66: 675676.
  • 149
    Babouee B, Widmer AF, Dubuis O et al. Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009–10. Euro Surveill 2011; 16: pii: 19817.
  • 150
    Poirel L, Schrenzel J, Cherkaoui A et al. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother 2011; 66: 17301733.
  • 151
    Huang TD, Bogaerts P, Berhin C et al. Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium. Euro Surveill 2011; 16: pii: 19900.
  • 152
    Bogaerts P, Montesinos I, Rodriguez-Villalobos H et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium. J Antimicrob Chemother 2010; 65: 361362.
  • 153
    Bogaerts P, Naas T, Wybo I et al. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. J Clin Microbiol 2006; 44: 41894192.
  • 154
    Glupczynski Y, Huang TD, Bouchahrouf W et al. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int J Antimicrob Agents 2012; 39: 168172.
  • 155
    Kalpoe JS, Al Naiemi N, Poirel L et al. Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands. J Med Microbiol 2011; 60: 677678.
  • 156
    Potron A, Poirel L, Bussy F et al. Occurrence of the carbapenem-hydrolyzing β-lactamase gene blaOXA-48 in the environment in Morocco. Antimicrob Agents Chemother 2011; 55: 54135414.
  • 157
    Leverstein-van Hall MA, Stuart JC, Voets GM et al. Carbapenem-resistant Klebsiella pneumoniae following foreign travel. Ned Tijdschr Geneeskd 2010; 154: A2013.
  • 158
    Bogaerts P, de Castro RR, Deplano A et al. Detection of a VIM-27-producing Klebsiella pneumoniae isolate in a patient following surgical tourism in Greece. Antimicrob Agents Chemother 2011; 55: 44884489.
  • 159
    Steinmann J, Kaase M, Gatermann S et al. Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. Euro Surveill 2011; 16: pii: 19944.
  • 160
    Wendt C, Schütt S, Dalpke AH et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010; 29: 563570.
  • 161
    Heller I, Grif K, Orth D. Emergence of VIM-1-carbapenemase-producing Enterobacter cloacae in Tyrol, Austria. J Med Microbiol 2012; 61: 567571.
  • 162
    Zarfel G, Hoenigl M, Würstl B et al. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001–2010. Clin Microbiol Infect 2011; 17: E5E8.
  • 163
    Zarfel G, Hoenigl M, Leitner E et al. Emergence of New Delhi metallo-β-lactamase, Austria. Emerg Infect Dis 2011; 17: 129130.
  • 164
    Baraniak A, Izdebski R, Herda M et al. The emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob Agents Chemother 2009; 53: 45654567.
  • 165
    Baraniak A, Grabowska A, Izdebski R et al. Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008–2009. Antimicrob Agents Chemother 2011; 55: 54935499.
  • 166
    Naas T, Cuzon G, Villegas MV et al. Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene. Antimicrob Agents Chemother 2008; 52: 12571263.
  • 167
    Leavitt A, Chmelnitsky I, Carmeli Y et al. Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258. Antimicrob Agents Chemother 2010; 54: 44934496.
  • 168
    Zacharczuk K, Piekarska K, Szych J et al. Emergence of Klebsiella pneumoniae coproducing KPC-2 and 16S rRNA methylase ArmA in Poland. Antimicrob Agents Chemother 2011; 55: 443446.
  • 169
    Sękowska A, Hryniewicz W, Gniadkowski M et al. Antimicrobial susceptibility of metallo-beta-lactamase positive and negative Klebsiella pneumoniae strains isolated from intensive care unit patients. Pol J Microbiol 2010; 59: 6769.
  • 170
    Hrabák J, Niemczyková J, Chudáčková E et al. KPC-2-producing Klebsiella pneumoniae isolated from a Czech patient previously hospitalized in Greece and in vivo selection of colistin resistance. Folia Microbiol (Praha) 2011; 56: 361365.
  • 171
    Tóth A, Damjanova I, Puskás E et al. Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary. Eur J Clin Microbiol Infect Dis 2010; 29: 765769.
  • 172
    Henwood CJ, Gatward T, Warner M et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother 2002; 49: 479487.
  • 173
    Woodford N, Zhang J, Warner M et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 2008; 62: 12611264.
  • 174
    Stone NRH, Woodford N, Livermore DM et al. Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-b-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis. J Antimicrob Chemother 2011; 66: 26772678.
  • 175
    Livermore DM, Warner M, Mushtaq S et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011; 37: 415419.
  • 176
    Roche C, Cotter M, O’Connell N, Crowley B. First identification of class A carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland. Euro Surveill 2009; 14: pii: 19163.
  • 177
    Prior AR, Roche C, Lynch M, Kelly S, O’Rourke K, Crowley B. First identified case of VIM-producing carbapenem-resistant Klebsiella pneumoniae in the Republic of Ireland associated with fatal outcome. Euro Surveill 2010; 15: pii: 19752.
  • 178
    Morris D, Boyle F, Ludden C et al. Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother 2011; 55: 49354936.
  • 179
    O’Brien DJ, Wrenn C, Roche C et al. First isolation and outbreak of OXA-48-producing Klebsiella 271 pneumoniae in an Irish hospital, March to June 2011. Euro Surveill 2011; 16: pii: 19921.
  • 180
    Samuelsen Ø, Thilesen CM, Heggelund L et al. Identification of NDM-1-producing Enterobacteriaceae in Norway. J Antimicrob Chemother 2011; 66: 670672.
  • 181
    Österblad M, Kirveskari J, Koskela S et al. First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009. Euro Surveill 2009; 14: pii: 19349.
  • 182
    Tegmark Wisell K, Haeggman S, Gezelius L et al. Identification of Klebsiella pneumoniae carbapenemase in Sweden. Euro Surveill 2007; 12: E071220.3.
  • 183
    Hammerum AM, Hansen F, Lester CH et al. Detection of the first two Klebsiella pneumoniae isolates with sequence type 258 producing KPC-2 carbapenemase in Denmark. Int J Antimicrob Agents 2010; 35: 610612.
  • 184
    Hammerum AM, Toleman MA, Hansen F et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010; 10: 829830.